Update on ICA-105665 clinical development plans for treatment of epilepsy and pain
Links shared publicly online about this topic.
- 1,208total visits
Update on ICA-105665 clinical development plans for treatment of epilepsy and pain
Icagen, Inc. today provided an update on clinical development plans for ICA-105665, the Company's novel drug candidate for the treatment of epilepsy and pain.
View full resource at news-medical.net
Tags: Pain, Seizure, Epilepsy, Drug, News
Most Recently Shared on April 28, 2010 at 12:07 pm By:
Epilepsy News: Update on ICA-105665 clinical development plans for treatment of epilepsy and pain: Icagen, Inc. to... http://bit.ly/aI9AaY
Advertisement
